Aegis Capital and Fordham Financial are bookrunners for the deal
By Susanna Moon
Chicago, July 13 - Ampio Pharmaceuticals, Inc.'s underwriters fully exercised the $2.5 million over-allotment option in the public offering of common stock that priced on Thursday. This brings the total deal size to $17.25 million.
Aegis Capital Corp. and Fordham Financial Management, Inc. are the bookrunners.
In all, the company sold 5,307,710 shares at $3.25 each, including the over-allotment option for 692,310 shares.
The share price is a 24.1% discount to the company's $4.28 closing share price on Wednesday.
Proceeds will be added to the company's general funds and used for general corporate purposes.
Ampio is a Greenwood Village, Colo.-based development-stage pharmaceutical company.
| Issuer: | Ampio Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $17,250,057.50 (including $2,250,007.50 greenshoe exercise)
|
| Shares: | 5,307,710
|
| Price: | $3.25
|
| Warrants: | No
|
| Bookrunners: | Aegis Capital Corp. and Fordham Financial Management, Inc.
|
| Pricing date: | July 12
|
| Settlement date: | July 18
|
| Stock symbol: | Nasdaq: AMPE
|
| Stock price: | $3.66 at close July 12
|
| Market capitalization: | $114.05 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
